SHERMAN JEFFREY W

CIK 00012304826 companiesNORTHBROOK, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001230482

Recent Transactions

50 trades

Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-08-28$7.92/sh−42,232→ 219,188 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2025-08-28−47,040→ 0 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-08-28$6.66/sh+47,040→ 261,420 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-06-04+50,000→ 214,380 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2025-05-13+19,000→ 19,000 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-06-05+50,000→ 164,380 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2024-05-29+19,000→ 19,000 total
Other
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-03-15+6,502→ 114,380 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-11-27$1.87/sh+5,400→ 5,400 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−19,044→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−105,808→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−9,314→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−9,200→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−4,654→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−12,226→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−12,696→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−80,944→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−45,352→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−2,655→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−3,809→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−27,942→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−4,599→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−11,426→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−4,599→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−18,397→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
2023-10-06−164,469→ 0 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2023-10-03+16,600→ 16,600 total
Gift
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-09-06−2,165→ 80,944 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-06-07+42,500→ 107,878 total
Gift
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-17−33,795→ 2,376 total
Gift
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-17+33,795→ 83,109 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-11$113.10/sh−3,368→ 36,171 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-10$113.05/sh−3,368→ 39,539 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-06$113.29/sh−5,187→ 49,314 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2023-01-05−9,314→ 9,314 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-05$113.24/sh−22,655→ 42,907 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2023-01-05−1,966→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2023-01-05−6,348→ 12,696 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2023-01-05−4,834→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2023-01-05−9,318→ 4,654 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2023-01-05−12,095→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-05+51,132→ 65,562 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2023-01-05−7,257→ 0 total
Award
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
2023-01-04+18,397→ 18,397 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2023-01-01−21,772→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-01+21,772→ 24,147 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-01-01$113.80/sh−9,717→ 14,430 total
Award
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2022-12-27+21,772→ 21,772 total
Award
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2022-12-27+13,972→ 13,972 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-12-12$111.45/sh−21,378→ 84,430 total

Companies

Recent Filings

Address

C/O HORIZON PHARMA, INC. 1033 SKOKIE BLVD., SUITE 355

NORTHBROOK, IL, 60062

View on SEC.gov